I think there is a better chance for this therapy because of the way it works, by transition the microglia over to an anti-inflammatory mode.
If this procedure passed safety trials I wouldn't be surprised if a similar therapy worked for schizophrenia, anxiety, and depression.
Mammals can still be incredibly distinct when you get down to specific biological pathway behavior. Or they can be exactly the same. Depends on how the mutation dice came up.
For example, the different ways various mammal species metabolize theobromine [1] (aka, the "dangerous" thing in chocolate).
Dogs and humans are similarly allergic, but because we metabolize it differently it's eliminated from our bodies much more quickly, which keeps it from building up to dangerous levels.
As my dad (vet / path / drug development) would say, 'Mother Nature is lazy before anything else. She'd rather repurpose an already evolved system than create something new in almost every circumstance.'
Multiply that by ~95 million years (last common dog-human ancestor), and you get a lot of quirky genetic code debt. ;)
My understanding is that "mice studies" cost less than clinical trials, therefore more "mice studies" with (correct/incorrect) conclusions are created.